Furthermore, to verify the association between EZH2 and LATS1 expression with public big data, we analyzed clinicopathological parameters based on TCGA cohort (mRNA) and TNM stage for ccRCC, pRCC, and chRCC. This evidence concerns the gene EZH2 and chromophobe renal cell carcinoma.